SCHEMBL18784208

SCHEMBL18784208

CCCS(=O)(=O)c1cccnc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
ALOX15 P16050 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
CYP3A4 P08684 1/20 0.46
BLM P54132 1/20 0.46
AGER Q15109 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP1A2 P05177 1/20 0.45
MYC P01106 1/20 0.42
COMT P21964 1/20 0.40
GAA P10253 2/20 0.39
ADRA2C P18825 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18784169 0.91 TSHR (0.45) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL15846978 0.89 KDM4E (0.50) TSHRHTTKDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL15846713 0.87 COMT (0.49) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL18940883 0.86 KDM4E (0.44) TSHRHTTKDM4EALDH1A1MAPT
Lithium Ion SCHEMBL18784188 0.85 TSHR (0.42) TSHRHTTKDM4EALDH1A1MAPT
Potassium Ion SCHEMBL18784182 0.85 TSHR (0.42) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL18784122 0.85 TSHR (0.42) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL1252476 0.78 KDM4E (0.53) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL18940891 0.78 KDM4E (0.43) TSHRHTTKDM4EALDH1A1MAPT
SCHEMBL17364349 0.77 KDM4E (0.58) TSHRHTTKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3162795-B1 METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID SUMITOMO CHEMICAL CO (JP) 2019-07-31 EP disclosed
US-9815786-B2 Method for manufacturing 3-(alkylsulfonyl)pyridine-2-carboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-14 US disclosed
US-20170129859-A1 METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-11 US disclosed
EP-3162795-A1 METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID Sumitomo Chemical Company, Limited (JP) 2017-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170129859-A1 METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID STS, SRM, CERS2 TSHR 957/4885HTT 3755/4885KDM4E 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.